{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:54:39Z","timestamp":1793501679835,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:00:00Z","timestamp":1682035200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["KL2-TR-002385"],"award-info":[{"award-number":["KL2-TR-002385"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020424","name":"Weill Cornell Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020424","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.ygyno.2023.04.006","type":"journal-article","created":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T18:25:09Z","timestamp":1682533509000},"page":"106-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Patient perspectives on risk-reducing salpingectomy with delayed oophorectomy for ovarian cancer risk-reduction: A systematic review of the literature"],"prefix":"10.1016","volume":"173","author":[{"given":"Luiza","family":"Perez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Webster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Bull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse T.","family":"Brewer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Danyal","family":"Ahsan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah R.","family":"Levi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn","family":"Cantillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloise","family":"Chapman-Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Holcomb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoshana M.","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa K.","family":"Frey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ygyno.2023.04.006_bb0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2014.09.009","article-title":"Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions","volume":"136","author":"Lancaster","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"11","key":"10.1016\/j.ygyno.2023.04.006_bb0015","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","article-title":"Meta-analysis of BRCA1 and BRCA2 penetrance","volume":"25","author":"Chen","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2023.04.006_bb0020","series-title":"National Comprehensive Cancer Network Guidelines Version 1.2023: Breast, Ovarian, and\/or Pancreatic Cancer Genetic Assessment","year":"2023"},{"issue":"28","key":"10.1016\/j.ygyno.2023.04.006_bb0025","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1200\/JCO.2005.04.5260","article-title":"ASCO\/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes","volume":"24","author":"Guillem","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2023.04.006_bb0030","doi-asserted-by":"crossref","first-page":"380","DOI":"10.6004\/jnccn.2020.0017","article-title":"NCCN guidelines insights: genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 1.2020","volume":"18","author":"Daly","year":"2020","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"3","key":"10.1016\/j.ygyno.2023.04.006_bb0035","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/AOG.0000000000002285","article-title":"Practice bulletin No. 182 summary: hereditary breast and ovarian cancer syndrome","volume":"130","year":"2017","journal-title":"Obstet. Gynecol."},{"issue":"15","key":"10.1016\/j.ygyno.2023.04.006_bb0040","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1158\/1078-0432.CCR-15-1465","article-title":"Effectiveness of prophylactic surgeries in BRCA1 or BRCA2 mutation carriers: a meta-analysis and systematic review","volume":"22","author":"Li","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2023.04.006_bb0045","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12905-014-0150-5","article-title":"Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers","volume":"14","author":"Marchetti","year":"2014","journal-title":"BMC Womens Health"},{"issue":"15","key":"10.1016\/j.ygyno.2023.04.006_bb0050","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1200\/JCO.2013.53.2820","article-title":"Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation","volume":"32","author":"Finch","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2023.04.006_bb0055","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ygyno.2018.04.564","article-title":"Bilateral salpingectomy with delayed oophorectomy for ovarian cancer risk reduction: a pilot study in women with BRCA1\/2 mutations","volume":"150","author":"Nebgen","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"7","key":"10.1016\/j.ygyno.2023.04.006_bb0060","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.humpath.2011.03.003","article-title":"Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm","volume":"42","author":"Kurman","year":"2011","journal-title":"Hum. Pathol."},{"issue":"25","key":"10.1016\/j.ygyno.2023.04.006_bb0065","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1200\/JCO.2007.12.2622","article-title":"Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction","volume":"25","author":"Callahan","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2023.04.006_bb0070","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/GCO.0b013e328011a21f","article-title":"The distal fallopian tube: a new model for pelvic serous carcinogenesis","volume":"19","author":"Crum","year":"2007","journal-title":"Curr. Opin. Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.ygyno.2023.04.006_bb0075","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1097\/AOG.0000000000003165","article-title":"ACOG Committee Opinion No. 774 summary: opportunistic salpingectomy as a strategy for epithelial ovarian Cancer prevention","volume":"133","year":"2019","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2023.04.006_bb0080","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.ygyno.2023.04.006_bb0085","author":"Institute, J.B"},{"issue":"2","key":"10.1016\/j.ygyno.2023.04.006_bb0090","first-page":"122","article-title":"Surgical decision making in premenopausal","volume":"59","author":"Gaba","year":"2022","journal-title":"J. Med. Genet."},{"issue":"2","key":"10.1016\/j.ygyno.2023.04.006_bb0095","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ygyno.2014.12.031","article-title":"Risk-reducing salpingectomy with delayed oophorectomy in BRCA1\/2 mutation carriers: patients\u2019 and professionals\u2019 perspectives","volume":"136","author":"Arts-de Jong","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2023.04.006_bb0100","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ygyno.2014.02.030","article-title":"Acceptability of prophylactic salpingectomy with delayed oophorectomy as risk-reducing surgery among BRCA mutation carriers","volume":"133","author":"Holman","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2023.04.006_bb0105","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/1471-0528.16424","article-title":"Attitudes towards risk-reducing early salpingectomy with delayed oophorectomy for ovarian cancer prevention: a cohort study","volume":"128","author":"Gaba","year":"2021","journal-title":"Bjog"},{"key":"10.1016\/j.ygyno.2023.04.006_bb0110","article-title":"\u201cIt was a no-brainer\u201d: a qualitative study of factors driving previvors\u2019 decision-making when considering risk-reducing salpingectomy with delayed oophorectomy","volume":"40","author":"Gellman","year":"2022","journal-title":"Gynecol. Oncol. Rep."},{"issue":"2","key":"10.1016\/j.ygyno.2023.04.006_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10020057","article-title":"Recommendations and choices for BRCA mutation carriers at risk for ovarian cancer: a complicated decision","volume":"10","author":"Lewis","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.ygyno.2023.04.006_bb0120","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jmig.2009.12.016","article-title":"Bilateral oophorectomy versus ovarian conservation: effects on long-term women\u2019s health","volume":"17","author":"Parker","year":"2010","journal-title":"J. Minim. Invasive Gynecol."},{"issue":"10","key":"10.1016\/j.ygyno.2023.04.006_bb0125","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S1470-2045(06)70869-5","article-title":"Survival patterns after oophorectomy in premenopausal women: a population-based cohort study","volume":"7","author":"Rocca","year":"2006","journal-title":"Lancet Oncol."},{"issue":"11","key":"10.1016\/j.ygyno.2023.04.006_bb0130","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1212\/01.wnl.0000276984.19542.e6","article-title":"Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause","volume":"69","author":"Rocca","year":"2007","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.ygyno.2023.04.006_bb0135","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1212\/01.wnl.0000280573.30975.6a","article-title":"Increased risk of parkinsonism in women who underwent oophorectomy before menopause","volume":"70","author":"Rocca","year":"2008","journal-title":"Neurology"},{"issue":"22","key":"10.1016\/j.ygyno.2023.04.006_bb0140","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1200\/JCO.2005.05.1896","article-title":"The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy","volume":"24","author":"Madalinska","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2023.04.006_bb0145","doi-asserted-by":"crossref","first-page":"E33","DOI":"10.1097\/NCC.0b013e3182642cb5","article-title":"Understanding the needs of women considering risk-reducing salpingo-oophorectomy","volume":"36","author":"Cherry","year":"2013","journal-title":"Cancer Nurs."},{"issue":"1","key":"10.1016\/j.ygyno.2023.04.006_bb0150","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1006\/gyno.2001.6556","article-title":"Worry about ovarian cancer risk and use of ovarian cancer screening by women at risk for ovarian cancer","volume":"85","author":"Andersen","year":"2002","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2023.04.006_bb0155","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/jamaoncol.2015.0658","article-title":"Effect of oophorectomy on survival after breast cancer in BRCA1 and BRCA2 mutation carriers","volume":"1","author":"Metcalfe","year":"2015","journal-title":"JAMA Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2023.04.006_bb0160","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s10897-016-0064-5","article-title":"Large, prospective analysis of the reasons patients do not pursue BRCA genetic testing following genetic counseling","volume":"26","author":"Hayden","year":"2017","journal-title":"J. Genet. Couns."},{"issue":"11","key":"10.1016\/j.ygyno.2023.04.006_bb0165","first-page":"1251","article-title":"Factors associated with decisions about clinical BRCA1\/2 testing","volume":"9","author":"Armstrong","year":"2000","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"5","key":"10.1016\/j.ygyno.2023.04.006_bb0170","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1158\/1055-9965.EPI-05-0002","article-title":"Uptake rates for breast cancer genetic testing: a systematic review","volume":"15","author":"Ropka","year":"2006","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"1","key":"10.1016\/j.ygyno.2023.04.006_bb0175","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1089\/gte.2006.9999","article-title":"The role of financial factors in acceptance of clinical BRCA genetic testing","volume":"11","author":"Kieran","year":"2007","journal-title":"Genet. Test."},{"issue":"1","key":"10.1016\/j.ygyno.2023.04.006_bb0180","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1089\/gte.2006.9998","article-title":"Factors associated with an individual\u2019s decision to withdraw from genetic testing for breast and ovarian cancer susceptibility: implications for counseling","volume":"11","author":"Godard","year":"2007","journal-title":"Genet. Test."},{"issue":"12","key":"10.1016\/j.ygyno.2023.04.006_bb0185","first-page":"1579","article-title":"Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women","volume":"11","author":"Thompson","year":"2002","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"4","key":"10.1016\/j.ygyno.2023.04.006_bb0190","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.amjsurg.2009.07.003","article-title":"Disparities in BRCA testing: when insurance coverage is not a barrier","volume":"198","author":"Olaya","year":"2009","journal-title":"Am. J. Surg."},{"issue":"3","key":"10.1016\/j.ygyno.2023.04.006_bb0195","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10897-005-0384-3","article-title":"Men\u2019s decision-making about predictive BRCA1\/2 testing: the role of family","volume":"14","author":"Hallowell","year":"2005","journal-title":"J. Genet. Couns."},{"key":"10.1016\/j.ygyno.2023.04.006_bb0200","first-page":"1","article-title":"Genetic testing for all: overcoming disparities in ovarian cancer genetic testing","volume":"42","author":"Frey","year":"2022","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"10.1016\/j.ygyno.2023.04.006_bb0205","author":"Quick Facts United States"},{"issue":"4","key":"10.1016\/j.ygyno.2023.04.006_bb0210","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/GIM.0b013e3182091ba4","article-title":"Underutilization of BRCA1\/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk","volume":"13","author":"Levy","year":"2011","journal-title":"Genet. Med."},{"issue":"6","key":"10.1016\/j.ygyno.2023.04.006_bb0215","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1001\/jamaoncol.2018.0340","article-title":"National distribution of cancer genetic testing in the United States: evidence for a gender disparity in hereditary breast and ovarian cancer","volume":"4","author":"Childers","year":"2018","journal-title":"JAMA Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2023.04.006_bb0220","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/s41436-018-0349-1","article-title":"Disparities in genetic services utilization in a random sample of young breast cancer survivors","volume":"21","author":"Nikolaidis","year":"2019","journal-title":"Genet. Med."},{"issue":"13","key":"10.1016\/j.ygyno.2023.04.006_bb0225","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1002\/cncr.30621","article-title":"Racial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivors","volume":"123","author":"Cragun","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2023.04.006_bb0230","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.cancergen.2019.04.063","article-title":"Uptake of genetic testing for germline BRCA1\/2 pathogenic variants in a predominantly Hispanic population","volume":"235-236","author":"McGuinness","year":"2019","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.ygyno.2023.04.006_bb0235","article-title":"Achieving universal genetic assessment for women with ovarian cancer: are we there yet? A systematic review and meta-analysis","author":"Jenny Lin","year":"2023","journal-title":"Gynecol. Oncol."},{"issue":"8","key":"10.1016\/j.ygyno.2023.04.006_bb0240","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1002\/humu.24053","article-title":"Mutation prevalence tables for hereditary cancer derived from multigene panel testing","volume":"41","author":"Hart","year":"2020","journal-title":"Hum. Mutat."},{"issue":"11","key":"10.1016\/j.ygyno.2023.04.006_bb0245","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/gim.2014.40","article-title":"Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients","volume":"16","author":"LaDuca","year":"2014","journal-title":"Genet. Med."},{"key":"10.1016\/j.ygyno.2023.04.006_bb0250","first-page":"35","article-title":"Racial and ethnic disparities in genetic testing at a hereditary breast and ovarian cancer center","author":"Chapman-Davis","year":"2020","journal-title":"J. Gen. Intern. Med."},{"issue":"3","key":"10.1016\/j.ygyno.2023.04.006_bb0255","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/cam4.1864","article-title":"Painting a portrait: analysis of national health survey data for cancer genetic counseling","volume":"8","author":"Stamp","year":"2019","journal-title":"Cancer Med."},{"issue":"1","key":"10.1016\/j.ygyno.2023.04.006_bb0260","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41436-018-0028-2","article-title":"Evaluating the role of public health in implementation of genomics-related recommendations: a case study of hereditary cancers using the CDC science impact framework","volume":"21","author":"Green","year":"2019","journal-title":"Genet. Med."},{"issue":"14","key":"10.1016\/j.ygyno.2023.04.006_bb0265","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1200\/JCO.2006.05.5889","article-title":"Disparities in genetic testing: thinking outside the BRCA box","volume":"24","author":"Hall","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2023.04.006_bb0270","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/GIM.0b013e3181770184","article-title":"Differential use of available genetic tests among primary care physicians in the United States: results of a national survey","volume":"10","author":"Shields","year":"2008","journal-title":"Genet. Med."},{"issue":"6","key":"10.1016\/j.ygyno.2023.04.006_bb0275","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s10897-010-9316-y","article-title":"Awareness, perceptions, and provider recommendation related to genetic testing for hereditary breast cancer risk among at-risk Hispanic women: similarities and variations by sub-ethnicity","volume":"19","author":"Vadaparampil","year":"2010","journal-title":"J. Genet. Couns."},{"issue":"9","key":"10.1016\/j.ygyno.2023.04.006_bb0280","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1001\/jamaoncol.2015.3048","article-title":"Utilization and outcomes of BRCA genetic testing and counseling in a national commercially insured population: the ABOUT study","volume":"1","author":"Armstrong","year":"2015","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.ygyno.2023.04.006_bb0285","first-page":"JCO2200303","article-title":"Cascade testing for hereditary cancer syndromes: should we move toward direct relative contact? A systematic review and meta-analysis","author":"Frey","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2023.04.006_bb0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1158\/1940-6207.CAPR-10-0345","article-title":"The search for unaffected individuals with Lynch syndrome: do the ends justify the means?","volume":"4","author":"Hampel","year":"2011","journal-title":"Cancer Prev. Res. (Phila.)"},{"issue":"34","key":"10.1016\/j.ygyno.2023.04.006_bb0295","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1200\/JCO.2017.73.6314","article-title":"National estimates of genetic testing in women with a history of breast or ovarian cancer","volume":"35","author":"Childers","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.ygyno.2023.04.006_bb0300","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/gim.2013.43","article-title":"Underutilization of lynch syndrome screening in a multisite study of patients with colorectal cancer","volume":"15","author":"Cross","year":"2013","journal-title":"Genet. Med."},{"issue":"2","key":"10.1016\/j.ygyno.2023.04.006_bb0305","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/jpm9020026","article-title":"Exploring predictors of genetic counseling and testing for hereditary breast and ovarian cancer: findings from the 2015 U.S. National Health Interview Survey","volume":"9","author":"Allen","year":"2019","journal-title":"J. Personal. Med."},{"issue":"1","key":"10.1016\/j.ygyno.2023.04.006_bb0325","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jamcollsurg.2015.03.033","article-title":"Variation in contralateral prophylactic mastectomy rates according to racial groups in young women with breast cancer, 1998 to 2011: a report from the National Cancer Data Base","volume":"221","author":"Grimmer","year":"2015","journal-title":"J. Am. Coll. Surg."},{"issue":"2","key":"10.1016\/j.ygyno.2023.04.006_bb0330","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jacr.2016.07.034","article-title":"Racial disparities in screening mammography in the United States: a systematic review and meta-analysis","volume":"14","author":"Ahmed","year":"2017","journal-title":"J. Am. Coll. Radiol."},{"issue":"4","key":"10.1016\/j.ygyno.2023.04.006_bb0335","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/cncr.29805","article-title":"Disparities in the use of screening magnetic resonance imaging of the breast in community practice by race, ethnicity, and socioeconomic status","volume":"122","author":"Haas","year":"2016","journal-title":"Cancer"},{"issue":"23","key":"10.1016\/j.ygyno.2023.04.006_bb0340","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.1002\/cncr.24623","article-title":"Surveillance of prophylactic mastectomy: trends in use from 1995 through 2005","volume":"115","author":"McLaughlin","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2023.04.006_bb0345","series-title":"To Prevent Cancer, More Women Should Consider Removing Fallopian Tubes, Experts Say","author":"Rabin","year":"2023"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825823001774?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825823001774?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:05:41Z","timestamp":1758773141000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825823001774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":65,"alternative-id":["S0090825823001774"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2023.04.006","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient perspectives on risk-reducing salpingectomy with delayed oophorectomy for ovarian cancer risk-reduction: A systematic review of the literature","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2023.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}